Procyon Corporation

What Procyon Corporation does

Procyon Corporation is a publicly traded holding company (ticker PCYN:OB on the OTC Bulletin Board), incorporated in Colorado in 1987 and headquartered in Oldsmar, Florida. Through its wholly-owned operating subsidiary AMERX Health Care Corporation (acquired in 1996), the company develops and markets proprietary advanced skin and wound care products under three core sub-brands: AMERIGEL (hydrogel wound dressings, post-op surgical kits, saline wound wash, care and barrier lotions) containing the proprietary broad-spectrum antimicrobial agent Oakin; HELIX3 Bioactive Collagen (collagen powder and collagen matrix); and AMERX Kits & Dressings (calcium alginate, foam, bordered foam, bordered gauze, hydrocolloid, and thin hydrocolloid dressings). The portfolio is rounded out by EXTREMIT-EASE compression garments and liners for extremity care.

The company's underlying technology centers on the Oakin ingredient, a proprietary broad-spectrum antimicrobial agent that is used across the AMERIGEL line and is supported by clinical research, case studies, and in-vitro laboratory studies. All formulations are FDA-registered and assigned National Drug Codes, and manufacturing is conducted under current Good Manufacturing Practices as defined under the FFDC Act.

Procyon operates a sales-led, direct distribution model targeting healthcare providers — physicians, hospitals, clinics, institutions, and schools — with a stated emphasis on lower extremity skin and wound conditions. Products are sold through one-time purchase (OTC and prescription) channels. The company also holds a Federal Supply Schedule contract enabling sales to federal government healthcare facilities. Revenue is generated from product sales across the AMERIGEL, HELIX3, AMERX, and EXTREMIT-EASE lines; pricing is not publicly disclosed.

Name

Procyon Corporation

Legal name

Procyon Corporation

Website

https://procyoncorp.com

Company type

Public

Founded year

1987

Operating status

Operating

Headcount range

1–10 employees

Short description

Procyon Corporation is a publicly traded holding company (PCYN:OB) that, through subsidiary AMERX Health Care Corporation, develops and markets FDA-registered proprietary skin and wound care products — including the AMERIGEL line with its Oakin antimicrobial ingredient — sold to physicians, hospitals, clinics, and federal healthcare facilities.

Ownership category

akta.pro rank

Product category

Wound Care Products

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Surgical & Medical Instruments & Apparatus (3841), Biological Products, (No Disgnostic Substances) (2836)

akta.pro industry

PRIMARYHLAHALAA

Advanced Wound Dressings (Foam, Hydrocolloid, Alginate, Hydrogel, Film)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products

SECONDARYHLAHALAE

Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products

SECONDARYHLAAAGAG

Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

• Wound care products
• Skin care products
• Antimicrobial dressings
• Bioactive collagen
• Compression garments

Headquarters

HQ city

Clearwater

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. AMERIGEL Advanced Skin & Wound Care Products: Sale of proprietary skin and wound care products including hydrogel wound dressing, post-op surgical kits, saline wound wash, care lotion, and barrier lotion through healthcare providers and OTC channels
2. HELIX3 Bioactive Collagen Products: Sale of collagen powder and collagen matrix products for wound care applications
3. AMERX Kits & Dressings: Sale of wound care kits, calcium alginate dressings, foam dressings, bordered dressings, and hydrocolloid dressings

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Procyon Corporation, through its wholly-owned subsidiary AMERX Health Care Corporation, develops, manufactures, and markets proprietary advanced skin and wound care products containing its Oakin broad-spectrum antimicrobial agent. The portfolio spans the AMERIGEL Advanced Skin & Wound Care line (hydrogel dressings, post-op surgical kits, saline wound wash, care lotion, barrier lotion), the HELIX3 Bioactive Collagen line (collagen powder and collagen matrix), the AMERX Kits & Dressings line (calcium alginate, foam, bordered foam, bordered gauze, hydrocolloid, and thin hydrocolloid dressings), and EXTREMIT-EASE compression garments and liners. Products are sold to physicians, hospitals, clinics, institutions, schools, and federal healthcare facilities via prescription and OTC channels.

Product overview

Procyon Corporation is a holding company for its subsidiary AMERX Health Care Corporation, which develops and markets advanced proprietary skin and wound care products. The company operates as a single-segment medical products business rather than a platform-plus-modules architecture. The product portfolio is organized around three core sub-brands: (1) AMERIGEL® Advanced Skin & Wound Care — the flagship line containing the proprietary broad-spectrum antimicrobial agent Oakin®, including hydrogel wound dressings, post-op surgical kits, saline wound wash, care lotion, and barrier lotion; (2) HELIX3® Bioactive Collagen — a collagen-based line featuring collagen powder and collagen matrix products for advanced wound care; and (3) AMERX® Kits & Dressings — a comprehensive line of wound care kits and various dressing types (calcium alginate, foam, bordered foam, bordered gauze, hydrocolloid, and thin hydrocolloid). Additionally, EXTREMIT-EASE® provides compression garments and liners. All products are proprietary formulations registered with the FDA and receive National Drug Codes. Manufacturing is performed under CGMP as defined under the FFDC Act.

Differentiator

Problem solved

Functional benefit

Brands

• AMERIGEL: Advanced skin and wound care product line containing proprietary broad-spectrum antimicrobial agent Oakin; includes Hydrogel Wound Dressing, Post-Op Surgical Kit, Saline Wound Wash, Care Lotion, and Barrier Lotion.
• HELIX3
• EXTREMIT-EASE

Products and services

• AMERIGEL Advanced Skin & Wound Care Product Line Flagship advanced skin and wound care product line containing the proprietary broad-spectrum antimicrobial agent Oakin; includes hydrogel wound dressings, post-op surgical kits, saline wound wash, care lotion, and barrier lotion. Used by physicians, healthcare providers, hospitals, clinics, institutions, and schools for treatment of wounds, ulcers, burns, surgical incisions, cuts, scrapes, abrasions, dermatitis, inflammation, and other skin problems.
• HELIX3 Bioactive Collagen Line Bioactive collagen product line including HELIX3-CP Collagen Powder and HELIX3-CM Collagen Matrix for advanced wound care applications.
• AMERX Kits & Dressings Line Line of wound care kits and dressings including wound care kits, calcium alginate dressings, foam dressings, bordered foam dressings, bordered gauze dressings, hydrocolloid dressings, and thin hydrocolloid dressings. All proprietary formulations are registered with the FDA and receive National Drug Codes.
• EXTREMIT-EASE Compression Garments & Liners Compression garments and liners for extremity care, marketed as a proprietary brand alongside AMERIGEL and HELIX3 for the treatment of lower extremity skin and wound conditions.

Quantifiable outcome

• AMERIGEL products are competitively priced and efficacious as proven by clinical research, case studies and in-vitro laboratory studies

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Federal Supply Schedule (FSS)coreChannel Partner/ Reseller/ DistributorAMERX Health Care Corporation was awarded a Federal Supply Schedule contract, enabling sales to federal government healthcare facilities. This contract was announced via Business Wire press release in June 2012.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Cardinal Health: Major healthcare distributor and medical products manufacturer offering wound care dressings through its Cardinal Health brand and through medical-surgical distribution. Comparable as a broad incumbent that distributes overlapping product categories to hospitals and clinics.
• Coloplast: Global leader in wound care and skin care including foam, hydrocolloid, and antimicrobial dressings under the Biatain brand. Comparable as a broad incumbent serving both wound care and skin barrier categories similar to Procyon's AMERIGEL and AMERX lines.
• Smith & Nephew: Global medical device company with a major Advanced Wound Management division offering hydrocolloid, foam, alginate, and antimicrobial dressings. Comparable as a broad incumbent in the same wound care categories served by Procyon's AMERX line.
• 3M Health Care (Solventum): Spun off from 3M in 2024, Solventum includes a large wound care and skin care portfolio covering advanced dressings, surgical tapes, and skin barriers. Comparable as a broad incumbent with overlapping product categories.

Direct peers

• Organogenesis: Regenerative medicine company focused on wound care and surgical biologics including Apligraf and Dermagraft skin substitutes and PuraPly antimicrobial wound matrix. Comparable through overlap with Procyon's HELIX3 collagen and AMERIGEL antimicrobial product lines.
• Mölnlycke Health Care: Specialty wound care company offering Mepilex foam dressings, Mepitel, and Exufiber gelling fiber dressings. Directly comparable in advanced wound dressings overlapping with Procyon's AMERX foam, alginate, and hydrocolloid offerings.
• Integra LifeSciences: Specialty medical device company with a dedicated Wound Care & Reconstruction segment including regenerative collagen dressings (Integra Dermal Regeneration Template) and traditional dressings. Comparable through overlap with Procyon's HELIX3 collagen matrix and AMERX dressing lines.
• ConvaTec: Specialty wound care company offering hydrocolloid, foam, antimicrobial, and collagen-based dressings. Directly comparable to Procyon's AMERIGEL and HELIX3 product lines, including overlap in advanced and biologic wound therapies.

Emerging players

• MiMedx Group: Regenerative medicine company selling placental tissue allografts (EpiFix, AmnioFix) for chronic wound care. Comparable as an emerging player in advanced biologic wound therapies, partially overlapping with Procyon's HELIX3 collagen franchise.

Others

• Medela (Wound Care): Medical device company traditionally focused on suction technology and negative pressure wound therapy (NPWT) systems. Adjacent to Procyon as a wound care ecosystem participant offering complementary (rather than directly competing) therapies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/procyon-corporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Procyon Corporation